---
figid: PMC2612755__nihms-78368-f0006
figlink: /pmc/articles/PMC2612755/figure/F5/
number: Figure 5
caption: Schematic diagram of a theoretical pancreatic endocrine tumor cell, smooth
  muscle cell (pericyte) or endothelial cell demonstrating the sites and mechanism
  of action of novel agents for the management of metastatic PETs. These cellular
  components of PETs all exhibit surface growth factor receptors (e.g., VEGFR, PDGFR,
  IGF-1R, c-KITR, etc) which when occupied by their respective growth factors (in
  an autocrine or paracrine manner) lead to autophosphorylation of the intracellular
  tyrosine kinase component of the receptor. Tyrosine kinase phosphorylation activates
  the PI3K-AKT-mTOR pathway (amongst others) ultimately promoting protein synthesis,
  cell cycle progression and cell survival which causes increased cellular proliferation,
  inhibition of apoptosis, cellular invasion, metastasis and tumor angiogenesis. This
  pathway can be inhibitied by monoclonal antibodies to growth factor receptors, tyrosine
  kinase inhibitors with specific activity against various growth factor receptors,
  or downstream mTOR inhibitors. Whilst mTOR inhibitors are active against both the
  tumor directly as well as its blood supply, tyrosine kinase inhibitors or antibodies
  directed against specific growth factors may predominantly effect the tumor itself
  or secondarily inhibit tumor cell growth by altering its blood supply-.
pmcid: PMC2612755
papertitle: 'Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors.'
reftext: David C. Metz, et al. Gastroenterology. ;135(5):1469-1492.
pmc_ranked_result_index: '62158'
pathway_score: 0.8786615
filename: nihms-78368-f0006.jpg
figtitle: A theoretical pancreatic endocrine tumor cell, smooth muscle cell (pericyte)
  or endothelial cell demonstrating the sites and mechanism of action of novel agents
  for the management of metastatic PETs
year: ''
organisms: Homo sapiens
ndex: f152e7b8-df19-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2612755__nihms-78368-f0006.html
  '@type': Dataset
  description: Schematic diagram of a theoretical pancreatic endocrine tumor cell,
    smooth muscle cell (pericyte) or endothelial cell demonstrating the sites and
    mechanism of action of novel agents for the management of metastatic PETs. These
    cellular components of PETs all exhibit surface growth factor receptors (e.g.,
    VEGFR, PDGFR, IGF-1R, c-KITR, etc) which when occupied by their respective growth
    factors (in an autocrine or paracrine manner) lead to autophosphorylation of the
    intracellular tyrosine kinase component of the receptor. Tyrosine kinase phosphorylation
    activates the PI3K-AKT-mTOR pathway (amongst others) ultimately promoting protein
    synthesis, cell cycle progression and cell survival which causes increased cellular
    proliferation, inhibition of apoptosis, cellular invasion, metastasis and tumor
    angiogenesis. This pathway can be inhibitied by monoclonal antibodies to growth
    factor receptors, tyrosine kinase inhibitors with specific activity against various
    growth factor receptors, or downstream mTOR inhibitors. Whilst mTOR inhibitors
    are active against both the tumor directly as well as its blood supply, tyrosine
    kinase inhibitors or antibodies directed against specific growth factors may predominantly
    effect the tumor itself or secondarily inhibit tumor cell growth by altering its
    blood supply-.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RRAD
  - VEGFA
  - VEGFD
  - VEGFC
  - KIT
  - VEGFB
  - PTEN
  - GNAT2
  - RAF1
  - PIK3R4
  - PIK3R5
  - FLT1
  - FLT4
  - EGFR
  - PDGFRA
  - MTOR
  - GNAI1
  - AKT2
  - GNAT1
  - PIK3CG
  - AKT3
  - KDR
  - PGF
  - MTTP
  - PDGFD
  - GNAI2
  - GNAI3
  - PIK3R6
  - PIK3CD
  - FLT3
  - GNAO1
  - RPTOR
  - PDGFRB
  - PIK3CB
  - AKT1
  - PDGFB
  - PIK3R3
  - GNAT3
  - PDGFC
  - ERBB2
  - GNAZ
  - PIK3CA
  - IGF1
  - PDGFA
  - Temsirolimus
  - Tyrosine
  - Rapamycin
  - Sirolimus
  - Cancer
genes:
- word: (RAD
  symbol: RAD
  source: hgnc_alias_symbol
  hgnc_symbol: RRAD
  entrez: '6236'
- word: (e.g.,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: (e.g.,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: (e.g.,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: c-Kit)
  symbol: C-Kit
  source: hgnc_alias_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: (e.g.,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: Raf-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: (VEGFR)
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: (VEGFR)
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: (EGFR)
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Sunitinib(VEGFR,PDGFR,c-Kit,FLT-3)
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
- word: c-Kit,
  symbol: C-Kit
  source: hgnc_alias_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: (VEGFR)
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: (e.g.,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: (Abl,
  symbol: ABL
  source: hgnc_alias_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: FLT-3)
  symbol: FLT3
  source: hgnc_symbol
  hgnc_symbol: FLT3
  entrez: '2322'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Sunitinib(VEGFR,PDGFR,c-Kit,FLT-3)
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: Gefitinib(EGFR,Her2)
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Tyrosine
  source: MESH
  identifier: D014443
- word: Rapamycin
  source: MESH
  identifier: D020123
- word: Sirolimus
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
